Join to View Full Profile
6431 Fannin StSte MsbHouston, TX 77030
Phone+1 713-500-6500
Fax+1 713-500-6497
Dr. Mathew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Antony Mathew is a gastroenterologist based in Houston, TX. He completed his residency in Internal Medicine at the University of Texas Health Science Center at Houston in 2023, following his graduation from Texas A&M Health Science Center College of Medicine in 2020. He has contributed several publications to the field, including studies on PD-1/PD-L1 inhibitor and statin therapy, the efficacy and safety of treatments for hepatocellular carcinoma, and the role of various factors in immune-mediated diarrhea and colitis among cancer patients. His work has been cited multiple times, indicating engagement with the scientific community.
Education & Training
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2020 - 2023
Texas A&M; Health Science Center College of MedicineClass of 2020
Certifications & Licensure
TX State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Differential Disease Behavior of Immune-Mediated Colitis Among Different Types of Immune Checkpoint Inhibition.Malek Shatila, Farzin Eshaghi, Carolina Colli Cruz, Antonio Pizuorno Machado, Antony Mathew
Targeted Oncology. 2025-03-01 - The Effect of PD-1/PD-L1 Inhibitor and Statin Combination Therapy on Overall Survival and Gastrointestinal Toxicity.Jay Shah, Andres Caleb Urias Rivera, Irene Jeong-Ah Lee, Kei Takigawa, Antony Mathew
American Journal of Clinical Oncology. 2025-03-01 - 4 citationsEfficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.Vincent Joerg, Bernhard Scheiner, Antonio D Alessio, Claudia A M Fulgenzi, Martin Schönlein
Hepatology Communications. 2023-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
